The Maryland Life Sciences Advisory Board makes recommendations to accelerate the growth of Maryland's biohealth industry and achieve recognition globally recognized as a Top 3 U.S. BioHealth Innovation Hub by 2023. Developed by the board over 10 months with the input of other industry experts and leaders, the recommendations are focused on four key areas that will help to strengthen Maryland's leadership in biohealth: assets, connectivity, capital and talent:
- Leverage and grow the state's assets and accelerate the commercialization of research;
- Increase connectivity among and awareness of the state's biohealth assets and resources;
- Increase availability and access to capital for Maryland biohealth businesses, from early-stage startups to advanced-stage companies;
- Grow the state's talent pool of experienced biohealth entrepreneurs, business leaders, graduates and scientists with commercially relevant experience.
To see the Life Sciences Advisory Board's full recommendations, click here. |
|
BioHealth and Life Sciences News
|
Rockville's Sucampo increases its focus on specialized diseases with high unmet need through its acquisition of Vtesse in a deal valued at $200M upfront .
Germantown's Epigenomics, focused on blood-based detection of cancers, agrees to a takeover by CFIC and BioChain in a transaction valued at $186M.
Gaithersburg's Emergent BioSolutions, Inc. receives $100M BARDA contract for BioThrax deliveries to the Strategic National Stockpile, and also signs a $53M modification to BARDA contract for the manufacture of Botulism Antitoxin.
Rockville's RegeneRx licencee obtains FDA permission to conduct a Phase 3 Trial of RGN-137 for Epidermolysis Bullosa in the United States.
Rockville's OncoImmune, developer of novel biopharmaceuticals for the treatment of cancer and autoimmune diseases,raises $15M.
Columbia's WellDoc enters joint commercial partnership agreement with Samsung for new consumer-focused diabetes health application.
Frederick's Rooster Bio, developer of standardized stem cell product platforms that enable rapid clinical and commercial translation, raises $6M in equity funding.
Baltimore's Sonavex receives $3M in financing, closing oversubscribed Series A.
Cumberland's Perineologic has distributed 5,000 Precision Point Transperineal Access System devices since they were approved by the FDA last year.
Bethesda's BrainScope unveils its new FDA-cleared, objective comprehensive head injury assessment device, BrainScope One, for urgent care clinics.
Baltimore's Vasoptic Medical raises $1.55M to support validation studies required for FDA approval of its point-of-care diabetic retinopathy diagnosis technology.
Rockville's REGENXBIO initiates Phase I/II clinical trial of RGX-501, the first AAV gene therapy treatment for Homozygous Familial Hypercholesterolemia (HoFH).
Frederick's Akonni Biosystems receives a $300K NIH contract to develop a simple, cost-effective device to purify DNA from Sputum for TB testing.
Baltimore's Intralytix receives GRAS (Generally Recognized As Safe) recognition from US Food and Drug Administration (FDA) for its product targeting Shigella.
Gaithersburg is home to ATCC's new cGMP-compliant biorepository.
Baltimore's SNBL (Shin Nippon Biomedical Labs.) sells majority stake in company to Pharmaron, which also recently acquired Germantown-based Xceleron.
Baltimore's InstantLabs Molecular Diagnostics secures investment from Angeon.
Potomac's GrekTek, developer of a patient wearable watch which can be used for managing health receives $100,000 from TEDCO's seed investment fund.
Baltimore's LifeSprout, a Hopkins spinout, wins 2nd annual Crab Trap competition.
BioHealth employers are invited by MABRC to complete a brief anonymous survey to help colleges better prepare students and their advisors for biohealth careers:
Attending BIO 2017 this June in San Diego? Let us know so that we can notify you of special programs in the Maryland Pavilion and events for Maryland attendees.
|
|
Upcoming Deadlines and Events
|
|
To view more job opportunities,
Brainscope (Bethesda) please check at the bottom of the
MARYLAND COMMERCE
|
|
Gain Visibility for Your Firm at BIO 2017 in San Diego
|
|
The Maryland Department of Commerce focuses on attracting, retaining, and expanding businesses and creating jobs in Maryland, and also markets Maryland's many assets to companies across the nation and abroad.
The Department's Office of BioHealth and Life Sciences supports innovative start-ups and companies focused on animal and human health, health IT, research tools, and related technologies. These include those involving agricultural and marine bio, biodefense, therapeutics, vaccines, diagnostics, medical devices, biologics, nutraceuticals, personalized and regenerative medicine, digital health, mHealth, telemedicine, EHR, bioinformatics, data center services, patient engagement, and wellness.
|
|
|
|
